Clinical Trial Update: Efficacy and Safety of Eltrombopag + CSA in Patients With Moderate Aplastic Anemia (EMAA) [Phase 2, Phase 3]

View source ↗

Summary

This update reports on the efficacy and safety of combining eltrombopag with cyclosporine A in patients with moderate aplastic anemia from Phase 2/Phase 3 trial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia

Drugs mentioned

• Cyclosporine A (cyclosporine)
• Eltrombopag (Promacta) (eltrombopag)

Snippet

Sponsor: B. Höchsmann | Conditions: Anemia, Aplastic | Phase 2, Phase 3 | Status: COMPLETED